跳至主要内容
临床试验/ACTRN12621000330842
ACTRN12621000330842尚未招募未知

The effect of FibroScan screening on detection of non-alcoholic fatty liver disease in type 2 diabetes patients attending a Diabetes Clinic: implementing the right care, in the right place, at the right time (NAFLD-RRR study)

PA Hospital Foundation0 个研究点目标入组 400 人开始时间: 2021年3月23日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Diagnosis
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Referred to a Diabetes Clinic for management of type 2 diabetes
  • Aged >/=18 years
  • Understand the consent procedures and give their full consent .
  • Consent to access their Queensland Health, primary care and Medicare Benefits
  • Schedule (MBS)/Pharmaceutical Benefits Schedule (PBS) data.

排除标准

  • Are pregnant.
  • Have advanced cardiac disease or another terminal illness.
  • NESB and interpreter not available

研究者

发起方
PA Hospital Foundation

相似试验